29
Views
10
CrossRef citations to date
0
Altmetric
Drug Profile

Mode of action and clinical use of imiquimod

&
Pages 151-159 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ayelen Tatiana Caimi, Cecilia Ramirez, Ana Paula Perez, Eder Lilia Romero & Maria Jose Morilla. (2022) In vitro anti-melanoma activity of imiquimod in ultradeformable nanovesicles. Drug Development and Industrial Pharmacy 48:11, pages 657-666.
Read now

Articles from other publishers (9)

Dhruv N. Desai, Ahmed Mahal, Rajat Varshney, Ahmad J. Obaidullah, Bhawna Gupta, Pratikhya Mohanty, Priyabrata Pattnaik, Nrusingha Charan Mohapatra, Snehasish Mishra, Venkataramana Kandi, Ali A. Rabaan & Ranjan K. Mohapatra. (2023) Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation. ACS Omega 8:31, pages 27953-27968.
Crossref
Zaw Thet, Alfred K. Lam, Dwarakanathan Ranganathan, Soe Yu Aung, Thin Han & Tien K. Khoo. (2021) Reducing non‐melanoma skin cancer risk in renal transplant recipients . Nephrology 26:11, pages 907-919.
Crossref
Kai-Cheng Chuang, Chuang-Rung Chang, Shu-Hao Chang, Shi-Wei Huang, Show-Mei Chuang, Zheng-Yi Li, Sin-Ting Wang, Jun-Kai Kao, Yi-Ju Chen & Jeng-Jer Shieh. (2020) Imiquimod-induced ROS production disrupts the balance of mitochondrial dynamics and increases mitophagy in skin cancer cells. Journal of Dermatological Science 98:3, pages 152-162.
Crossref
Katarina Trčko. (2020) Imiquimod-Associated Erythema Multiforme. Acta Dermatovenerologica Alpina Pannonica et Adriatica 29:1.
Crossref
Frank Blanco-Pérez, Garibald Papp, Alexandra Goretzki, Tobias Möller, Martina Anzaghe & Stefan Schülke. (2019) Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies. Archivum Immunologiae et Therapiae Experimentalis 67:5, pages 273-293.
Crossref
Rodrigo Rocco, Nadia Alegre, Roberto Pozner, Rosa Wainstok & Silvina Gazzaniga. (2018) Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod. Toxicology Letters 288, pages 82-88.
Crossref
Jonathan Laiño, Andrea Wangorsch, Frank Blanco, Sonja Wolfheimer, Maren Krause, Adam Flaczyk, Tobias-Maximilian Möller, Mindy Tsai, Stephen Galli, Stefan Vieths, Masako Toda, Stephan Scheurer & Stefan Schülke. (2017) Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice. Journal of Immunology Research 2017, pages 1-12.
Crossref
G. Das, B. Tan & K. Nicholls. (2016) Safety and efficacy of a novel short occlusive regimen of imiquimod for selected non-melanotic skin lesions in renal transplant patients. Internal Medicine Journal 46:3, pages 352-355.
Crossref
Anushree Seth, Min Beom Heo & Yong Taik Lim. (2014) Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy. Biomaterials 35:27, pages 7992-8001.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.